International Journal of Diabetes Mellitus
Volume 1, Issue 1 , Pages 2-6 , April 2009

Adding rosiglitazone to metformin in patients with type 2 diabetes: Effect on diabetes control and metabolic parameters

  • Hussein Raef

      Affiliations

    • Department of Medicine (MBC-46), King Faisal Specialist Hospital and Research Center (KFSH & RC), P.O. Box 3354, Riyadh 11211, Saudi Arabia
    • Corresponding Author InformationCorresponding author. Tel.: +966 1 442 7490; fax: +966 1 442 4771.
    • ,
  • Abdulraof Al-Mahfouz

      Affiliations

    • Department of Medicine (MBC-46), King Faisal Specialist Hospital and Research Center (KFSH & RC), P.O. Box 3354, Riyadh 11211, Saudi Arabia
    • ,
  • Abdullah Al-Khonaizan

      Affiliations

    • Department of Family Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

  • Image Result

    Mean HbA1C level of patients at base line and at the end of the study.

    Mean HbA1C level of patients at base line and at the end of the study.

  • Image Result

    Mean FBG level for all patients at base line and at the end of the study.

    Mean FBG level for all patients at base line and at the end of the study.

  • Image Result

    Mean free fatty acid levels (μeq/L) for all patients at base line, 8 weeks and at the end of the study.

    Mean free fatty acid levels (μeq/L) for all patients at base line, 8 weeks and at the end of the study.

  • Image Result

    Mean LDL, HDL, and TG levels for all patients at base line and at the end of the study, there were no significant changes in LDL and TG levels, but a significant increase in HDL.

    Mean LDL, HDL, and TG levels for all patients at base line and at the end of the study, there were no significant changes in LDL and TG levels, but a significant increase in HDL.

  • Image Result

    Mean weight, BMI and waist diameter for all patients at base line and at the end of the study, there was mild but significant gain of weight and increase in BMI at the end of the study, but no signifi

    Mean weight, BMI and waist diameter for all patients at base line and at the end of the study, there was mild but significant gain of weight and increase in BMI at the end of the study, but no significant change in waist diameter.

  • Image Result
    Mean systolic and diastolic BPs at base line and at the end of the study. There was no significant change in BPs.

    Mean systolic and diastolic BPs at base line and at the end of the study. There was no significant change in BPs.

PII: S1877-5934(09)00002-2

doi: 10.1016/j.ijdm.2009.03.001

International Journal of Diabetes Mellitus
Volume 1, Issue 1 , Pages 2-6 , April 2009

Article Tools

* Image Usage & Resolution